Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Madariaga, J. R.
Right arrow Articles by Starzl, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Madariaga, J. R.
Right arrow Articles by Starzl, T. E.

Annals of Surgical Oncology, Vol 2, Issue 6 483-487, Copyright © 1995 by Society of Surgical Oncology

ARTICLES

Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma

J. R. Madariaga, I. R. Marino, D. D. Karavias, M. A. Nalesnik, H. R. Doyle, S. Iwatsuki, J. J. Fung and T. E. Starzl
Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania, USA.

BACKGROUND: Hepatic epithelioid hemangioendothelioma (PHEHE) is a multifocal, low-grade malignant neoplasia characterized by its epithelial-like appearance and vascular endothelial histogenesis. The outcome of 16 patients treated with orthotopic liver transplantation (OLT) is the subject of this report. METHODS: A retrospective study of 16 patients with HEHE (7 men, 9 women) with ages ranging from 24 to 58 years (mean 37 +/- 10.6 years). Follow-up intervals ranged from 1 to 15 years (median of 4.5 years). RESULTS: Actual patient survival at 1, 3, and 5 years was 100, 87.5, and 71.3%, respectively. Disease-free survival at 1, 3, and 5 years was 81.3, 68.8, and 60.2%, respectively. The 90-day operative mortality was 0. Involvement of the hilar lymph nodes or vascular invasion did not affect survival. The 5-year survival of HEHE compares favorably with that of hepatocellular carcinoma at the same stage (stage 4A): 71.3 versus 9.8% (p = 0.001) CONCLUSIONS: The long-term survival obtained in this series justifies OLT for these tumors even in the presence of limited extrahepatic disease.


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
P. Bagan, M. Hassan, F. L. P. Barthes, S. Peyrard, R. Souilamas, C. Danel, and M. Riquet
Prognostic Factors and Surgical Indications of Pulmonary Epithelioid Hemangioendothelioma: A Review of the Literature
Ann. Thorac. Surg., December 1, 2006; 82(6): 2010 - 2013.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
F. Earnest IV and C. D. Johnson
Case 96: hepatic epithelioid hemangioendothelioma.
Radiology, July 1, 2006; 240(1): 295 - 298.
[Full Text] [PDF]

Home page
 JRSMHome page
E. Haydon, G. Haydon, S. Bramhall, A D. Mayer, and D. Niel
Hepatic epithelioid haemangioendothelioma
J R Soc Med, August 1, 2005; 98(8): 364 - 365.
[Full Text] [PDF]

Home page
 ChestHome page
J. Kpodonu, C. Tshibaka, M. G. Massad, D. Arenberg, and P. Cronin
The Importance of Clinical Registries for Pulmonary Epithelioid Hemangioendothelioma
Chest, May 1, 2005; 127(5): 1870 - 1871.
[Full Text] [PDF]

Home page
 The OncologistHome page
M. Hertl and A. B. Cosimi
Liver Transplantation for Malignancy
Oncologist, April 1, 2005; 10(4): 269 - 281.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
I. D. Lyburn, W. C. Torreggiani, A. C. Harris, C. V. Zwirewich, A. R. Buckley, J. E. Davis, S. W. Chung, C. H. Scudamore, and S. G. F. Ho
Hepatic Epithelioid Hemangioendothelioma: Sonographic, CT, and MR Imaging Appearances
Am. J. Roentgenol., May 1, 2003; 180(5): 1359 - 1364.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the Society of Surgical Oncology.